|
Zimvie complaint number (b)(4).A4: weight unknown / not provided.D10: umua-tsv3525-17s, tapered screw-vent® universal multi-unit abutment; 3.5mm(d) x 2.5mm(h) x 17.° customer has indicated that the product is in process of being returned to zimvie for investigation.Once the investigation has been completed, a follow-up mdr will be submitted.
|
|
This report is being submitted to relay additional information and device evaluation.Correction: h1: type of reportable event was updated from serious injury to malfunction the following sections are being reported: b4: date of this report was updated.D9: device availability and return date were updated.G3: date received by manufacturer was updated.G6: type of report was updated.H1: type of reportable event was updated.H2: type of follow up was updated.H3: device evaluated by manufacturer was updated.H6: type of investigation codes were added: 4109, 4111 and 3331.H6: investigation findings code was added: 180.H6: investigation conclusions code was added: 4307.H11: narrative/data was updated.Zimvie received the reported implant for evaluation.Visual evaluation and a functional test were performed, the implant has signs of use.The abutments screws drive feature was worn.During a functional test, the abutment does not disengage/release from implant.Dhr review was completed for the subject lot number.No deviations or non-conformances, which could have caused or contributed to the reported event, were noted as part of the dhr.Complaint history review was performed for the reported lot number for similar events and no other complaint was identified.Based on the investigation and risk management file review, the most likely root cause determined from the investigation was customer error, applying to much torque/speed during seating.Therefore, based on the available information, device malfunction did occur.The abutment could not be removed from implant.The reported event was confirmed.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the products were nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.
|